Power3 Medical , Three Hundred Patient Clinical Validation Study of Its Nuropro(R) Diagnostic Test for Alzheimer's and Parkinson's Disease

Mar 13 2008 - Power3 Medical Products, Inc. (OTCBB: PWRM), a leading proteomics company specializing in the development and commercialization of diagnostic tests for the early detection of breast cancer and neurodegenerative diseases, commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer’s disease and Parkinson’s disease... Power3 Medical's Press Release -